✦ LIBER ✦

Experience with selegiline and levodopa in advanced Parkinson's disease

✍ Scribed by A. Lieberman; E. Fazzini

Book ID: 114783546
Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 412 KB
Volume: 84
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1991.tb05022.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa, bromocriptine and selegiline m

Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease

✍ Tarja H. Haapaniemi; Mika A. Kallio; Juha T. Korpelainen; Kalervo Suominen; Uole 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 232 KB

Early selegiline therapy reduces levodop

Early selegiline therapy reduces levodopa dose requirement in Parkinson's disease

✍ V. V. Myllylä; E. H. Heinonen; J. A. Vuorinen; O.I. Kilkku; K. A. Sotaniemi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

Pharmacokinetics and effects of levodopa

Pharmacokinetics and effects of levodopa in advanced Parkinson's disease

✍ E. Bredberg; J. Tedroff; S.-M. Aquilonius; L. Paalzow 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 557 KB

Five patients with severe Parkinson's disease were characterized with respect to their pharmacokinetic and pharmacodynamic responses to levodopa given: orally, intravenously (three different infusion rates) and intraduodenally. The best therapeutic infusion rate in the intravenous study was used for

Deprenyl (selegiline) combined with levo

Deprenyl (selegiline) combined with levodopa and a decarboxylase inhibitor in the treatment of Parkinson's disease

✍ JAN PRESTHUS; ALAJOS HAJBA 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

Piribedil as an adjunct to levodopa in a

Piribedil as an adjunct to levodopa in advanced Parkinson's disease: the Asian experience

✍ Virgilio Gerald H. Evidente; Raymund P. Esteban; Francis M. Domingo; Lourdjean O 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Selegiline and mortality in Parkinson's

Selegiline and mortality in Parkinson's disease

✍ Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 2 views

## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran